section head, vascular medicine and intervention
Massachusetts General Hospital
boston, Massachusetts, United States
Dr. Rosenfield is a Master of SCAI and Section Head for Vascular Medicine and Intervention in the Division of Cardiology at Massachusetts General Hospital. He earned a masters degree in Health Care Delivery Science from Dartmouth College. Dr. Rosenfield is a master clinician and interventionalist has dedicated much of his career to educating fellows, residents, students, and colleagues. He received the distinguished Laennec award for his outstanding teaching and mentorship. As a researcher and clinical trialist, he designed and served as national principle investigator for several landmark studies, including Aspire 2, Levant 2, Superb, ACT 1, and NIH BEST-CLI trial. He served as President of SCAI and was President of the MA ACC, serving on the Board of Governors of ACC. Dr. Rosenfield is a founding member of VIVA, a 501c3 organization, founder of the National PERT Consortium.
Disclosure information not submitted.
My Experiences with Lead and Radiation Protection
Saturday, March 8, 2025
3:13 PM – 3:21 PM ET
Panel Discussion | Radiation Protection - Call for Action
Saturday, March 8, 2025
4:09 PM – 4:25 PM ET
PRO CON DEBATE | ANTICOAGULATION VERSUS ENDOVASCULAR THERAPY FOR ACUTE PULMONARY EMBOLISM
Monday, March 10, 2025
11:30 AM – 12:00 PM ET
DIAGNOSIS AND MANAGEMENT OF PULMONARY EMBOLISM
Monday, March 10, 2025
1:30 PM – 2:45 PM ET
Monday, March 10, 2025
2:26 PM – 2:45 PM ET
LATE BREAKING CLINICAL TRIALS | ENDOVASCULAR
Tuesday, March 11, 2025
8:00 AM – 9:00 AM ET